Elston MS, Boyle V, Conaglen JV, et al. Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand. Intern Med J. 2024;54(11):1814-1820. doi:10.1111/ imj.16511.

Mulatero P, Araujo-Castro M, Pacak K, et al. Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline. Eur J Endocrinol. 2024;190(4):G1-G12. doi:10.1093/ejendo/lvae029

Zeman J, Veldhuisen DJ, Kamilaris C, et al. Glucocorticoid Remediable Aldosteronism in a Family with a Strong History of Cerebral Aneurysms and Hypertension. Prague Med Rep. 2025;126(3):151-154. doi:10.14712/23362936.2025.23.

Young WF Jr. Diagnosis and management of primary aldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000– [updated 2018 Feb 8; cited 2024 Dec 6].

Scott JH, Menouar MA, Dunn RJ. Physiology, Aldosterone. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan– [updated 2023 May 1]. PMID: 29261963.

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5): 1889–916. do

Young WF Jr. Diagnosis and management of primary aldosteronism. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000–. [updated 2018 Feb 8; cited 2024 Dec 6].

Scott JH, Menouar MA, Dunn RJ. Physiology, Aldosterone. 2023 May 1. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 29261963.

Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The mana- gement of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016; 101(5):1889-916. d